Permissive nicotine regulation as a complement to traditional tobacco control.
BACKGROUND
Cigarette smoking takes a staggering toll on human health and attracts considerable public health attention, yet real solutions seem distant. The 2004 Family Smoking Prevention and Tobacco Control Act (US Senate bill S2461) would have given the US Food and Drug Administration limited authority to regulate cigarettes to "protect the public health." However, such legislation is unlikely to substantially reduce smoking or related deaths.


CONCLUSIONS
The past 500 years of tobacco control efforts demonstrate that nicotine prohibition is a practical impossibility for numerous reasons, state revenue being one of the most ominous. The FDA already has regulatory authority over pharmaceutical grade nicotine products, and requires pharmacists to dispense the most addictive of these only with prescriptions. Meanwhile, every corner store can sell far more addictive and dangerous cigarettes to any adult. The FDA could immediately increase competition between cigarettes and clean nicotine products by approving available nicotine products for over-the-counter sales to adults. Similarly permissive regulation of cigarettes and addictive nicotine products will reduce tobacco use and improve smokers' health, but increase nicotine use in the population. Fortunately, restricted youth access and accurate labeling of nicotine's absolute risks will dissuade many non-smokers from experimenting with it, while accurate depiction of its risks relative to cigarette smoking will encourage many smokers to switch. The FDA could take a series of small steps that might ultimately replace a large proportion of cigarette smoking with equally addictive nicotine products, without risking serious public health setbacks. Vaccine, methadone, and injury prevention policies establish relevant public health precedents.


CONCLUSIONS
Cigarettes, or an equally addictive alternative, will be a permanent and common product in most societies. Regulations restricting only the safest addictive nicotine products are hard to justify. Addictive nicotine compliments other tobacco control strategies. Modern tobacco control policies are applicable to addictive nicotine. Controlled trials and test market studies are urgently needed to evaluate addictive nicotine as an alternative to smoking. Meanwhile, legislators should preserve the Food and Drug Administration's option to permit non-prescription sales of addictive nicotine.
Sumner
Walton
W
Department of Medicine, Washington University School of Medicine, St, Louis, Missouri, USA. wsumner@im.wustl.edu
D033161:Government Regulation; D006801:Humans; D009538:Nicotine / Q000592:standards*; D011634:Public Health; D012449:Safety; D000074606:Smoking Prevention; D011049:Social Control Policies; D019460:Tobacco Industry / Q000331:legislation & jurisprudence*; D020340:Tobacco Use Cessation; D014481:United States; D014486:United States Food and Drug Administration
D009538:Nicotine
JAMA. 2000 Dec 20;284(23):2995-6
11122580
N Z Med J. 2004 Mar 12;117(1190):U801
15107904
Addiction. 2002 Oct;97(10):1347-54
12359039
Food Drug Law J. 1998;53 suppl:75-114
10342981
Head Neck. 2001 Oct;23(10):860-70
11592233
Addiction. 1997 May;92(5):615-33
9219386
Eur J Pharmacol. 2002 Apr 19;441(1-2):115-25
12007928
Psychopharmacology (Berl). 1998 Oct;139(3):288-90
9784088
Tob Control. 2003 Jun;12(2):124-32
12773720
Pharmacol Biochem Behav. 2001 Dec;70(4):561-70
11796154
Behav Genet. 1999 Nov;29(6):423-31
10857247
Curr Opin Investig Drugs. 2004 Apr;5(4):430-5
15134285
Arch Dis Child. 1995 Dec;73(6):549-51
8546517
J Environ Pathol Toxicol Oncol. 1996;15(2-4):169-72
9216801
Arch Environ Health. 1995 Sep-Oct;50(5):384-9
7574894
Br Med Bull. 1996 Jan;52(1):58-73
8746297
Chest. 1996 Feb;109(2):438-45
8620719
Tob Control. 2003 Dec;12(4):372-3
14660770
J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):630-41
11392340
J Toxicol Clin Toxicol. 1996;34(6):691-8
8941198
Alcohol Clin Exp Res. 1995 Oct;19(5):1111-20
8561278
Addiction. 2001 Dec;96(12):1757-68
11784468
Tob Control. 2003 Jun;12 Suppl 1:i14-24
12773782
JAMA. 2002 Sep 11;288(10):1260-4
12215133
Addiction. 2000 Jan;95 Suppl 1:S25-8
10723819
Am J Med Sci. 1994 Jul;308(1):32-4
8010334
Lancet. 2003 Sep 13;362(9387):847-52
13678970
Food Drug Law J. 1998;53 suppl:1-8
10342978
Ann Vasc Surg. 1998 Jan;12(1):41-5
9451995
Inj Prev. 2000 Dec;6(4):277-80
11144627
Nicotine Tob Res. 2003 Apr;5(2):237-43
12745497
JAMA. 1997 Oct 1;278(13):1087-92
9315768
Calcif Tissue Int. 1999 Sep;65(3):246-9
10441660
Expert Opin Emerg Drugs. 2004 May;9(1):39-53
15155135
Health Psychol. 1998 Jan;17(1):56-62
9459071
Psychol Addict Behav. 2003 Dec;17(4):332-5
14640830
Ann Intern Med. 1997 Mar 1;126(5):364-71
9054280
Am J Public Health. 2000 Mar;90(3):401-3
10705858
MMWR Morb Mortal Wkly Rep. 2003 Sep 5;52(35):842-4
12966360
Br J Obstet Gynaecol. 1996 Aug;103(8):806-13
8760712
Nicotine Tob Res. 2000 Feb;2(1):45-52
11072440
MMWR Morb Mortal Wkly Rep. 2002 Jul 26;51(29):642-5
12186222
Tob Control. 2003 Dec;12(4):349-59
14660766
Tob Control. 1997 Autumn;6(3):254-61
9396113
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Aug;80(2):178-82
7552882
Epidemiol Rev. 2003;25:60-4
12940231
Psychopharmacology (Berl). 1994 Nov;116(3):382-4
7892431
Br J Addict. 1991 May;86(5):653-8
1859935
Crit Rev Oral Biol Med. 2004;15(5):252-63
15470264
Br J Addict. 1990 Feb;85(2):279-91
2180511
J Pharmacol Exp Ther. 1998 Jun;285(3):931-45
9618392
Semin Perinatol. 1996 Apr;20(2):115-26
8857697
Mutat Res. 2002 Nov 26;521(1-2):137-49
12438011
Annu Rev Pharmacol Toxicol. 1996;36:597-613
8725403
Life Sci. 1996;58(16):1339-46
8614291
Soc Sci Med. 1991;32(9):989-1005
2047903
J Trauma. 1972 Mar;12(3):193-207
5012817
Alcohol Clin Exp Res. 2001 May;25(5 Suppl ISBRA):152S-156S
11391065
Physiol Behav. 2001 Sep 1-15;74(1-2):213-26
11564471
Nicotine Tob Res. 2002;4 Suppl 2:S61-71
12580158
South Med J. 1993 Sep;86(9):989-92
8367763
Food Drug Law J. 1998;53 suppl:11-42
10342979
Science. 1976 Dec 11;194(4271):1243-6
996552
Food Drug Law J. 1998;53 suppl:43-74
10342980
FASEB J. 1993 Aug;7(11):1045-51
8370474
MMWR Morb Mortal Wkly Rep. 2003 Apr 11;52(14):303-4, 306-7
12731700
Tob Control. 2003 Dec;12(4):360-7
14660767
Drug Saf. 2001;24(4):277-322
11330657
Psychopharmacology (Berl). 1999 Sep;146(2):199-204
10525756
Acta Paediatr Suppl. 1993 Jun;82 Suppl 389:70-2
8374198
Toxicol Appl Pharmacol. 2002 Jan 1;178(1):8-14
11781074
Lancet. 2003 Dec 6;362(9399):1865
14667736
World J Biol Psychiatry. 2003 Apr;4(2):49-55
12692774
Psychoneuroendocrinology. 1998 Feb;23(2):175-87
9621397
Tob Control. 2001 Sep;10(3):201-3
11544374